Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Spinraza fda approval december 2016?Spinraza market share?Amoxicillin powder vs capsule?Tapazole generic name?Prevalite powder cost?
See the DrugPatentWatch profile for invega
No. Invega Sustenna (paliperidone palmitate) is a long-acting injectable antipsychotic made from chemical drug manufacturing, not a gene-editing or genome-engineering technology. CRISPR is used for cutting/modifying DNA in research and certain experimental therapies, and it is not part of the way Invega Sustenna is produced or administered.
CRISPR is relevant to therapies that involve editing a person’s genetic material (for example, some gene-editing treatments in clinical trials). Invega Sustenna is a small-molecule/medication product that works by acting on neurotransmitter receptors rather than changing DNA, so CRISPR would not be part of the product concept.
If you’re trying to confirm whether a product involves CRISPR, look for descriptions such as “gene editing,” “CRISPR,” “genome editing,” or “CRISPR-Cas.” For Invega Sustenna, the key information is about the active ingredient (paliperidone palmitate) and its delivery as a long-acting injection, not genetic modification.
Other Questions About Invega :